Signaling
Signaling
Background
Membranes
Hormones & Receptors
Second Messengers
Signaling
• Introduction
Lipid Bilayer
Organization of Bilayer
Around Cell
Signal Response
Nerve System Signaling
Hormones and Signal Transduction
• Hormones
Thyroid Hormone
Epinephrine
Progesterone
Hormones and Signal Transduction
• Introduction
Receptor Binding
Inside Cell
Hormones and Signal Transduction
• Receptors
Intracellular
Domain
Seven Transmembrane
Membrane Bound Domains
Binding of Hormone
Hormone
Structural Change of Receptor
GPCR Action Cycle
Return to
Original
State
Ca++ Ca++
Ca++ Ca++
Ca ++
Ca++
β
Epi
Ep i
γ
n ep
n ep
Epinephrine
hrin
hrin
e
e
GPCR
β
GPCR GPCR +
γ
Resting State GTP GDP Active
Hormones and Signal Transduction
β-adrenergic Receptor Signaling
Second
ATP Messenger
Adenylate
Adenylate
Cyclase
Cyclase
cAMP + PPi
Transmits Signal
Hormones and Signal Transduction
• Actions of the Second Messenger
Catalytic Subunits
Regulatory Subunits
Activated
Protein 4 cAMP
Kinase A
Activity
Altered
by
Phosphorylation
(Inactive)
Hormones and Signal Transduction
• G-Protein Coupled Receptors Outline
Receptor
G-Proteins
Protein Kinase A
Kinase Cascade
Turning Signal Off
The Coffee Connection
Hormones and Signal Transduction
• β-adrenergic Receptor Signaling
3 cAMP
2 ATP
4
PKA PKA-Reg Protein Kinase A
5a
5
PK-P PK Phosphorylase Kinase
Glycogen
Synthase
GS-P GS
6
P-GP-a GP-b Glycogen Phosphorylase
7
Glycogenx-1 Glycogenx
Glucose-1-phosphate
Hormones and Signal Transduction
• PKA Activation
Hormones and Signal Transduction
• Turning Off β-adrenergic Receptor Signaling
β-adrenergic Receptor
G-Protein
cAMP
Protein Kinase A
Hormones and Signal Transduction
• Turning Off β-adrenergic Receptor Signaling
ATP ADP
G-Protein
Receptor Arrestin
PO
PO
Kinase
4 =
4 =
Cytoplasm
Blocks and
Favors Endocytosis
Hormones and Signal Transduction
• β-adrenergic Receptor Signaling
G-protein Inactivation
Auto-regulating
Inherent GTPase Activity
β
γ
Hydrolysis
β
γ
Phosphate
PO4=
PO4=
X
Hormones and Signal Transduction
• β-adrenergic Receptor Signaling
PO4=
cAMP Ph
o sp
ho
die
ste
ras
PKA e
AMP
PK-P
GS-P
Glycogenx-1 Glycogenx
Glucose-1-phosphate
Hormones and Signal Transduction
• β-adrenergic Receptor Signaling
PO4=
cAMP Ph
o sp Phosphodiesterase is
ho
die
ste Inhibited by Caffeine
ras
PKA e
AMP
PK-P
GS-P
ATP ADP
RTK
Receptor Tyrosine Kinases (RTKs)
Outside of Cell
Lipid Bilayer
Ligand
(Hormone)
Binding &
Dimerization
Activation of Tails
Autophosphorylation P P
P P
Active Tyrosine
PP
Kinase
Receptor Tyrosine Kinases (RTKs)
Assembly of
Signaling Complex
P P P P
P P P P
PP PP
SH2 Domains of
Signaling Complex
Proteins Recognize and
Communicates Message to
Bind Phosphotyrosines
Cell (usually by phosphorylation)
Receptor Tyrosine Kinases (RTKs)
• RTK Signaling Overview
Binding of Hormone to
RTK in Membrane
Receptor
Dimerization
Autophosphorylation
Signaling
Complex
Assembly
Communicate
Message
to Cell
RTKs - Insulin Receptor
Other
Signaling Pathways
PK GS PDK1 Activation
Active Inactive
PIP3 Formation
GP-a PI3 Kinase Activation
Active
IRS-1 Activation
Glycogen Broken Down
Tyrosine Kinase Activation
Blood Glucose Levels Rise
Insulin Receptor Pathway
RTKs - Epidermal Growth Factor
EGF
EGFR
RTKs - Epidermal Growth Factor
Autophosphorylated
Tyrosines in
Cytoplasmic Domain
Signaling Complex
Assembled on
Phosphotyrosines
GTP
GTP GDP
Prepares Cell for Division
RTKs - Epidermal Growth Factor
Autophosphorylated
Tyrosines in
Cytoplasmic Domain
Signaling Complex
Assembled on
Phosphotyrosines
GTP
GTP GDP
Prepares Cell for Division
RTKs - Epidermal Growth Factor
RAS Activates RAF Kinase
MEK Activates
MAP Kinase Cascade
Transcription Factor
Phosphorylation
Activates Gene Expression
RAS
Bound GDP
RTKs Summary
1
5. Transcription
3
Nucleus
4
Cell
Lipid Bilayer
HSP Release
Hormone Entry Dimerization Movement
to Nucleus
Steroid Hormone Signaling
Transcription
Activation
Prostaglandin H2 Thromboxane A2
Signaling Gone Wild
• Signaling Gone Wild
Other Mutations
Bcr-Abl
Fusion
The bcr-abl fusion links the
tyrosine kinase of abl
with the N-terminus
and transcription control of bcr
bcr bcr-abl fusion
Crossover
22 22/9
Gleevec has Almost Doubled the Five Year Survival Rate of CML Patients
Other Signaling Considerations